Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.
about
Intraoperative near-infrared imaging can distinguish cancer from normal tissue but not inflammationSurgical cytoreduction restores the antitumor efficacy of a Listeria monocytogenes vaccine in malignant pleural mesothelioma.Adenoviral-based immunotherapy provides local disease control in an orthotopic murine model of esophageal cancer.Cytoreduction surgery reduces systemic myeloid suppressor cell populations and restores intratumoral immunotherapy effectiveness.Intraoperative near-infrared imaging of surgical wounds after tumor resections can detect residual disease.Andrographis paniculata elicits anti-invasion activities by suppressing TM4SF3 gene expression and by anoikis-sensitization in esophageal cancer cellsChanges in the local tumor microenvironment in recurrent cancers may explain the failure of vaccines after surgeryA positive-margin resection model recreates the postsurgical tumor microenvironment and is a reliable model for adjuvant therapy evaluation.Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.Adapting conventional cancer treatment for immunotherapy.Phase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant gliomaThe adjuvant value of Andrographis paniculata in metastatic esophageal cancer treatment - from preclinical perspectives.Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma.Local Immunotherapy of Cancer: Innovative Approaches to Harnessing Tumor-Specific Immune Responses.
P2860
Q33968244-57ABE065-4509-4307-A3FB-6A022ED2F146Q35768107-AE40850B-CE46-4139-B490-78C1FFEEE38CQ36004154-3647AF1F-4081-42A1-90EC-91392DA6EC6EQ36161355-8D1E91F5-8F41-49B1-BAB5-57738F9B59C4Q36351260-4BB32336-D7C2-457B-8A80-33935677A428Q36516573-13E7AA46-1139-4A46-A959-39DC8930A7A7Q36583022-E69199EA-E8D2-4693-BE53-732C4E790F67Q36710130-8F580FDA-D8DE-45BF-BFA2-F6BD1DF81430Q38115968-4AFFA60D-E0AE-4017-AE9B-51A838125408Q38748185-35A86169-8337-49E9-B9D0-3AD3F1790D74Q38912327-5E9710E8-AB5D-4A23-A0E0-B0FEE196B654Q41881308-7888B5CB-FE34-4007-96C0-C73D1E17D8FAQ42153454-8BF7D150-C96E-4AAB-B952-FA9E5702E354Q52353493-04607A59-F151-4D02-86C3-BD08563FA555
P2860
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Neoadjuvant in situ gene-media ...... c esophageal carcinoma models.
@ast
Neoadjuvant in situ gene-media ...... c esophageal carcinoma models.
@en
type
label
Neoadjuvant in situ gene-media ...... c esophageal carcinoma models.
@ast
Neoadjuvant in situ gene-media ...... c esophageal carcinoma models.
@en
prefLabel
Neoadjuvant in situ gene-media ...... c esophageal carcinoma models.
@ast
Neoadjuvant in situ gene-media ...... c esophageal carcinoma models.
@en
P2093
P2860
P356
P1433
P1476
Neoadjuvant in situ gene-media ...... c esophageal carcinoma models.
@en
P2093
A K Rustgi
E Aguilar-Cordova
H Nakagawa
J D Predina
L A Aliperti
S M Albelda
P2860
P2888
P304
P356
10.1038/CGT.2011.56
P577
2011-08-26T00:00:00Z